Comment Resolutions: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 78: | Line 78: | ||
| 2021.12.16 | | 2021.12.16 | ||
| [[Media:QIBATechnicalConfirmationResolutions MRE.pdf| Technical Confirmation Resolutions 2022-02-14]] | | [[Media:QIBATechnicalConfirmationResolutions MRE.pdf| Technical Confirmation Resolutions 2022-02-14]] | ||
|- | |- | ||
| [[Media:QIBA_DWIProfile_Stage3_15Dec2022_v3.pdf | MR Diffusion-Weighted Imaging (DWI) of the Apparent Diffusion Coefficient (ADC) 2022-12-15]] | | [[Media:QIBA_DWIProfile_Stage3_15Dec2022_v3.pdf | MR Diffusion-Weighted Imaging (DWI) of the Apparent Diffusion Coefficient (ADC) 2022-12-15]] | ||
|Clinically Feasible | | Clinically Feasible | ||
|2022.12.15 | | 2022.12.15 | ||
|Clinically Feasible 2022-12-15 | | [[Media:QIBA DWI-MR Clinical Feasibility Resolutions.pdf| Clinically Feasible Resolutions 2022-12-15]] | ||
|- | |- | ||
| colspan="4" align="center" style="background:#dddddd" | '''PET/NM Profiles''' | | colspan="4" align="center" style="background:#dddddd" | '''PET/NM Profiles''' | ||
Revision as of 18:28, 17 February 2023
Comments received during Public Comment, Clinically Feasible (formerly Technical) Confirmation, or during a Profile ballot, are reviewed by the originating Biomarker Committee.
Per the QIBA Process, committees record how each collected comment was resolved and those resolutions are posted here.